First of all thank you for this platform.
May i know Sir from your experience, what are the most effective strategies for managing intrafraction motion during SBRT, particularly in spine and lung cases?
Join us in Philadelphia for our Mid-Atlantic Regional Symposium with insightful clinical talks by renowned clinical experts and inspirational discussions on SRS and SBRT.
Experience cutting edge of radiotherapy and radiosurgery at our exciting two days symposium focused on precision, personalization, and standardization in Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT).
This event will bring together medical physicists, dosimetrists, radiation oncologists and radiation therapists to share valuable clinical techniques and innovative management strategies, as well as to gain insights into how complex data is reshaping the field of radiosurgery.
Brainlab Mid-Atlantic Regional Symposium
May 8 and 9, 2026
Click here to have the program.
We look forward to welcoming you to Philadelphia for this inspiring event!
To register click here
We’re pleased to host the Advanced Clinical Course "Brain Metastases and Skull-base Tumors" in cooperation with Universitätsklinikum Hamburg-Eppendorf and the clinical team of Prof. Dr. med. Cordula Petersen and Dipl.-Phys. Manuel Todorovic.
This course will provide participants with the opportunity to learn from clinical experts about the clinical implementation and requirements for a successful radiosurgery program for brain metastases and skull-base tumors. During the course, medical physicists will learn about specific quality assurance techniques as well as expert tricks for treatment planning with Brainlab radiosurgery software. Radiation oncologists and neurosurgeons will learn about contouring, clinical prescriptions and planning approaches.
More information here.
Interested? Contact your local Brainlab Sales representative.
*Please note: A Brainlab Academy ticket is needed to be able to attend this course.
We’re pleased to host the Advanced Clinical Course “ExacTrac Dynamic for Breast Cancer” in cooperation with the Universitair Ziekenhuis Brussel and the clinical team of Thierry Gevaert, PhD.
This course is a comprehensive training program aimed at supporting the use of ExacTrac Dynamic for breast cancer treatments. Attendees will learn about specific imaging, CT simulation, breath-hold techniques, and general strategies for treating breast cancer and will familiarize themselves with using the ExacTrac Dynamic Breath-Hold modules.
More information here.
Interested? Contact your local Brainlab Sales representative.
*Please note: A Brainlab Academy ticket is needed to be able to attend this course.
We’re pleased to host the Brainlab Academy: Essential Course Radiosurgery in Chicago.
This course is a three-day classroom training designed for clinicians pursuing full proficiency with Brainlab radiosurgery treatment planning systems. The session is hosted at the state-of-the-art training center in the Wrigley building.
Please find more information here: Essential Course Radiosurgery | Brainlab
Interested? Contact your local Brainlab Sales representative.
*Please note: This course is for US-customers only. A Brainlab Academy ticket is needed to be able to attend this course.
For more than a decade, Instituto Zunino in Córdoba, Argentina has been recognized as a regional reference center for high-precision radiotherapy. Built on long-standing clinical expertise and a strong culture of quality, the center has developed a mature SRS and SBRT program that continues to evolve through structured processes, external validation and a commitment to shared learning.
The team’s journey with Brainlab technology began in 2009 with iPlan RT and expanded in 2011 with ExacTrac X-Ray. Today, RT Elements is clinically adopted across the department of four treatment machines, supported by ExacTrac Dynamic—forming the technical backbone of daily practice.
A benchmark for quality: Novalis Certification
At Instituto Zunino, maintaining excellence means welcoming independent evaluation. First Novalis Certified in 2016, and successfully re-certified in 2020 and 2025, the team has consistently demonstrated its commitment to quality, safety and transparency. The most recent re-certification reinforces the center’s alignment with international standards and its place within the Novalis Certified community.
Why certification matters—in their own words
Silvia Zunino, MD, PhD, Director and Founder of Instituto Zunino and Fundación Marie Curie, explains: “Novalis Certification confirms that we work according to the same standards as leading centers in the United States and Europe. It gives us confidence in our methods and supports continuous improvement.”
Daniel Venencia, PhD, Head of Medical Physics, adds: “Even as an experienced institution, having our work audited helps us identify opportunities to improve. Clearly defined protocols and external review ensure our patients receive the best possible treatment.” Motivated by his commitment to excellence in SRS and SBRT and to support his colleagues, Daniel Venencia has now joined the Novalis Certification Program team as an auditor.
Beyond the clinic: sharing expertise to advance the region
Instituto Zunino’s impact extends beyond its own walls. Through Fundación Marie Curie, the team actively supports regional development by sharing protocols, workflows and clinical experience with the wider medical community. Every two years, the foundation hosts an internationally recognized SRS & SBRT congress (Congreso sobre Avances Integrados en Oncología, Radiocirugía y Física Médica: Innovación y Precisión en el tratamiento del cancer), bringing together physicians, physicists and researchers for high-level exchange. A dedicated hands-on workshop focused on Brainlab technology offers open insight into clinical workflows, physics considerations and decision-making processes—earning a strong reputation across the region. As Daniel Venencia notes: “Advancing treatment techniques, software, automation and artificial intelligence—and helping others do the same—is how we move the field forward together.”
Stories from the Circle: leadership through openness
Instituto Zunino shows that leadership in radiosurgery and radiotherapy is not defined by outcomes alone. By combining long-standing expertise with education, openness and a sustained commitment to Novalis Certification, the team actively contributes to raising standards across the region.
We’re proud to share Instituto Zunino’s story and to recognize the team’s ongoing commitment to collaboration, clinical rigor and patient-centered care.
The statements made by the clinician represent their personal opinion and experience. These statements may not be supported by scientific evidence or peer-reviewed research. For verified information about the device, please refer to the manufacturer's official documentation.
Picture: ©Instituto Zunino, Córdoba, Argentina
At the University Hospital for Radiation Oncology Innsbruck, prostate cancer treatment is built on precision and teamwork. Treating 15–20 patients each day, the department has refined an implanted marker workflow that gives clinicians full control over imaging and positioning. Under Professor Ute Ganswindt’s leadership, the team has made accuracy a shared focus across every step of care.
The challenge: motion that doesn’t wait - Even in treatments lasting only a few minutes, the prostate can shift without warning. In Innsbruck, this unpredictable movement appeared in one third of monitored sessions. Small deviations could accumulate across a VMAT arc with the potential to affect dose coverage and increase toxicity. To move toward shorter, more efficient treatment schedules, the team needed a way to quantify and correct that motion reliably in real time.
The innovation: an implanted marker workflow built for precision - Using the Brainlab ExacTrac Dynamic implanted marker workflow, the Innsbruck team was able to detect and correct for prostate motion. Continuous X-ray monitoring of fiducial markers helped clinicians maintain target alignment throughout treatment and prevent deviations from building over time. With marker implantation performed directly within the radiation oncology department, the workflow also allowed seamless integration with imaging and planning protocols and ensured strong ownership of each step.
The shift: confidence to move toward ultra-hypofractionation - With precise, reliable motion management in place, the team began transitioning from conventional and moderately hypofractionated regimens to ultra-hypofractionated protocols. Their goal was clear: shorten the overall treatment pathway while maintaining the accuracy necessary to protecting nearby healthy structures and minimizing toxicity. The established collaboration across teams and the efficiency and precision of the implanted marker workflow provided the necessary foundation to make that shift safely.
In their words: “Progress like this only happens when everyone is aligned around the same goal: delivering precise, reliable care for every patient, every day. The collaboration across teams and the efficiency of the implanted marker workflow provided the foundation we needed to make that shift safely.” – Dr. Angela Ginestet, Radiation Oncologist, University Hospital for Radiation Oncology Innsbruck.
The impact: precision that supports patient-centered treatments - A recent evaluation from the University Hospital for Radiation Oncology Innsbruck confirmed that the implanted marker workflow with ExacTrac Dynamic accurately identified and corrected clinically relevant motion during prostate treatments. For a department committed to delivering precise care at high daily volumes, this capability is helping shape a future where shorter treatment schedules can coexist with uncompromised accuracy.
Please join us in celebrating the Innsbruck team for leading the way toward ultra-hypofractionated prostate cancer care. If you want to learn more about their work, read the study here: https://pubmed.ncbi.nlm.nih.gov/37523057/
Picture: ©Tirol Kliniken Innsbruck, Dr. Julian Mangesius, Dr. Angela Ginestet, University Hospital for Radiation Oncology, Innsbruck, Austria
The statements made by the clinician represent their personal opinion and experience. These statements may not be supported by scientific evidence or peer-reviewed research. For verified information about the device, please refer to the manufacturer's official documentation.
Big News! 🎉 We are excited to announce that the Brainlab Novalis Circle 10th International Conference is happening on September 17-19, 2026, in the vibrant city of Munich, Germany!
Mark your calendars and get ready for two full days of cutting-edge scientific talks and thought-provoking discussions, featuring some of the most brilliant minds in the world of stereotactic radiosurgery and stereotactic body radiation therapy.
It’s going to be an unforgettable event, and we can’t wait to see you there!
You can find more information here: Novalis Circle Conference 2026 | Brainlab
You're invited to a Brainlab Novalis Circle webinar on Wednesday, September 24, taking place just ahead of the ASTRO Annual Meeting.
Improved decision making with longitudinal brain metastases management
Join us for two expert presentations highlighting the latest advancements in radiosurgery for brain metastases. The session will conclude with an interactive Q&A.
Agenda:
Early retreatment based on Elements Contrast Clearance Analysis leads to improved outcomes in patients with brain metastases
@Dheerendra Prasad, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Clinical workflow optimization via new AI solutions
@Wenyin Shi, MD, PhD, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Date: Wednesday, September 24, 2025
Time: 1:00 PM PT | 4:00 PM ET | 10:00 PM CET
Don't miss this opportunity to hear from leading researchers and clinicians shaping the future of radiosurgical treatment.
We look forward to seeing you there!
Exciting News!
Join us in Nashville, Tennessee for the Brainlab Regional Symposium happening November 14 and 15, 2025!
This 2 day symposium will bring together clinicians, physicists, and innovators from across the region to explore the latest breakthroughs in radiation oncology, featuring Brainlab’s cutting-edge SRS and SBRT solutions. From cranial SRS to extracranial treatments like DIBH breast, prostate, and lung applications — there's something for every aspect of clinical practice.
Agenda is coming soon
Click here to register
Looking forward to seeing you there!
Thank you to the team at Philippine General Hospital for welcoming Poon Cyrus and I this week. It has been a joy making new connections and sharing our Brainlab product knowledge with you all.
#togetherwe
Exciting News!
Join us in Columbus, Ohio for the Brainlab Regional Symposium— our first U.S. event of the year — happening June 13–14, 2025!
This 1½-day symposium will bring together clinicians, physicists, and innovators from across the region to explore the latest breakthroughs in radiation oncology, featuring Brainlab’s cutting-edge SRS and SBRT solutions. From cranial SRS to extracranial treatments like DIBH breast, prostate, and lung applications — there's something for every aspect of clinical practice.
Pleas find the agenda attached
Click https://lnkd.in/e3e7czKn to register or scan the QR code in the attached flyer.
Looking forward to seeing you there!